Chemical formula: C₁₇H₁₇ClN₂O Molecular mass: 300.79 g/mol PubChem compound: 30768
Taking into account the data available, it is preferable as a safety measure to avoid using etifoxine during the pregnancy whatever is the term. Indeed the animal data are reassuring but the clinical data are insufficient.
Attention is drawn, of vehicle drivers and machinery operators in particular, to the risks of drowsiness associated with this medicine.
Slight drowsiness, occurring at the start of treatment and disappearing spontaneously with its continuation.
Rare skin rashes, very rare allergic reactions in the form of urticaria and angio-edema.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
